212 related articles for article (PubMed ID: 26276749)
1. Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer.
Ahn-Jarvis JH; Clinton SK; Grainger EM; Riedl KM; Schwartz SJ; Lee ML; Cruz-Cano R; Young GS; Lesinski GB; Vodovotz Y
Cancer Prev Res (Phila); 2015 Nov; 8(11):1045-54. PubMed ID: 26276749
[TBL] [Abstract][Full Text] [Related]
2. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells.
Lesinski GB; Reville PK; Mace TA; Young GS; Ahn-Jarvis J; Thomas-Ahner J; Vodovotz Y; Ameen Z; Grainger E; Riedl K; Schwartz S; Clinton SK
Cancer Prev Res (Phila); 2015 Nov; 8(11):1036-44. PubMed ID: 26276751
[TBL] [Abstract][Full Text] [Related]
3. Design and selection of soy breads used for evaluating isoflavone bioavailability in clinical trials.
Ahn-Jarvis JH; Riedl KM; Schwartz SJ; Vodovotz Y
J Agric Food Chem; 2013 Mar; 61(12):3111-20. PubMed ID: 23451757
[TBL] [Abstract][Full Text] [Related]
4. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women.
Richelle M; Pridmore-Merten S; Bodenstab S; Enslen M; Offord EA
J Nutr; 2002 Sep; 132(9):2587-92. PubMed ID: 12221213
[TBL] [Abstract][Full Text] [Related]
5. Increased probiotic yogurt or resistant starch intake does not affect isoflavone bioavailability in subjects consuming a high soy diet.
Larkin TA; Price WE; Astheimer LB
Nutrition; 2007 Oct; 23(10):709-18. PubMed ID: 17656069
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans.
Izumi T; Piskula MK; Osawa S; Obata A; Tobe K; Saito M; Kataoka S; Kubota Y; Kikuchi M
J Nutr; 2000 Jul; 130(7):1695-9. PubMed ID: 10867038
[TBL] [Abstract][Full Text] [Related]
7. Modification of isoflavone profiles in a fermented soy food with almond powder.
Park M; Jeong MK; Kim M; Lee J
J Food Sci; 2012 Jan; 77(1):C128-34. PubMed ID: 22182181
[TBL] [Abstract][Full Text] [Related]
8. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
Gardner CD; Oelrich B; Liu JP; Feldman D; Franke AA; Brooks JD
Prostate; 2009 May; 69(7):719-26. PubMed ID: 19180569
[TBL] [Abstract][Full Text] [Related]
9. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.
Allred CD; Twaddle NC; Allred KF; Goeppinger TS; Churchwell MI; Ju YH; Helferich WG; Doerge DR
J Agric Food Chem; 2005 Nov; 53(22):8542-50. PubMed ID: 16248551
[TBL] [Abstract][Full Text] [Related]
10. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial.
Dewell A; Weidner G; Sumner MD; Barnard RJ; Marlin RO; Daubenmier JJ; Chi C; Carroll PR; Ornish D
Nutr Cancer; 2007; 58(1):35-42. PubMed ID: 17571965
[TBL] [Abstract][Full Text] [Related]
11. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
[TBL] [Abstract][Full Text] [Related]
12. Higher bioavailability of isoflavones after a single ingestion of aglycone-rich fermented soybeans compared with glucoside-rich non-fermented soybeans in Japanese postmenopausal women.
Okabe Y; Shimazu T; Tanimoto H
J Sci Food Agric; 2011 Mar; 91(4):658-63. PubMed ID: 21104834
[TBL] [Abstract][Full Text] [Related]
13. Isoflavone profile and biological activity of soy bread.
Zhang YC; Albrecht D; Bomser J; Schwartz SJ; Vodovotz Y
J Agric Food Chem; 2003 Dec; 51(26):7611-6. PubMed ID: 14664516
[TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
[TBL] [Abstract][Full Text] [Related]
15. Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk.
Reverri EJ; LaSalle CD; Franke AA; Steinberg FM
Mol Nutr Food Res; 2015 Feb; 59(2):323-33. PubMed ID: 25351805
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
17. Conversion of major soy isoflavone glucosides and aglycones in in vitro intestinal models.
Islam MA; Punt A; Spenkelink B; Murk AJ; Rolaf van Leeuwen FX; Rietjens IM
Mol Nutr Food Res; 2014 Mar; 58(3):503-15. PubMed ID: 24668774
[TBL] [Abstract][Full Text] [Related]
18. Comparison of regulative functions between dietary soy isoflavones aglycone and glucoside on lipid metabolism in rats fed cholesterol.
Kawakami Y; Tsurugasaki W; Nakamura S; Osada K
J Nutr Biochem; 2005 Apr; 16(4):205-12. PubMed ID: 15808324
[TBL] [Abstract][Full Text] [Related]
19. Impact of food matrix on isoflavone metabolism and cardiovascular biomarkers in adults with hypercholesterolemia.
Ahn-Jarvis J; Clinton SK; Riedl KM; Vodovotz Y; Schwartz SJ
Food Funct; 2012 Oct; 3(10):1051-8. PubMed ID: 22739802
[TBL] [Abstract][Full Text] [Related]
20. Microbial metabolism of soy isoflavones by human intestinal bacterial strains.
Tsuchihashi R; Sakamoto S; Kodera M; Nohara T; Kinjo J
J Nat Med; 2008 Oct; 62(4):456-60. PubMed ID: 18648905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
